Novartis CEO says U.S. exit from global health programmes to affect millions
The American CEO of Swiss drugmaker Novartis on Friday warned that the United States' exit from the World Health Organization ...
Hosted on MSN10mon
Novartis begins expansion of Singapore biopharmaceutical plant
Novartis has broken ground on the expansion of its biopharmaceutical manufacturing facility in Singapore with an investment of $256m aimed at meeting the increasing demand in the Asian market.
Business Insider5y
Swiss drug giant Novartis has done $60 billion in deals over the past 18 months. One sentence from its CEO reveals the core strategy.
When Vas Narasimhan started as the new CEO of the Swiss drug giant Novartis, he began refocusing the company on a key business area: prescription medicines. Until recently, alongside top-selling ...
pharmaphorum12y
Big M&As unlikely, says Novartis CEO
The CEO of Swiss pharma company, Novartis, has said that while the company is facing pressures from expired patents on key drugs, it is unlikely to conduct any big mergers or acquisitions in the ...